The Global Point-of-Care Molecular Diagnostics Market Size is expected to reach USD 11.84 Billion by 2032, at a CAGR of 5.3% during the forecast period 2022 to 2032. Point-of-care molecular diagnostics (POC MDx) is a rapidly advancing field in medical technology that enables rapid and accurate detection of infectious diseases, genetic disorders, and other medical conditions at the patient's bedside or in a clinical setting, without the need for complex laboratory infrastructure.